Member of Investment Committee @ Corporate Venture Fund for non-disclosed Corporate Parent (January 2024 - Present)
Angel Investor (seed to growth stage) @ several Healthtech and Life sciences companies (March 2022 - Present)
Member of the Board of Directors (Verwaltungsrat) @ (May 2022 - November 2025)
Partner, Healthcare @ (June 2022 - October 2024)
Head of Business Development @ Roche Diagnostics Information Solutions @ (July 2019 - May 2022)
Head of Partnering and Collaborations @ Roche Diagnostics Information Solutions @ (September 2016 - June 2019)
Roche Venture Fund Investment Director @ (April 2008 - August 2016)
Roche Venture Fund Investment Manager @ (April 2005 - April 2008)
Roche Venture Fund Investment Analyst @ (August 2002 - April 2005)
Board Member @ Viewics, Inc. (acquired by Roche) (June 2015 - July 2016)
Board Member @ mySugr (March 2015 - July 2016)
Board Representative @ (March 2009 - July 2016)
CFO @ Adello Inc (August 2013 - January 2014)
CFO @ Adello Group AG (February 2013 - January 2014)
Cofounder @ Apptraction (January 2011 - January 2012)
Head of Investment Management @ GSL Galli, Schneider & Lehner (January 2000 - March 2002)
Intern @ Invision AG (a member of Metro Group) (January 1997 - January 1997)
Simon Meier Education
University of St.Gallen 1994-1999
Kantonsschule Solothurn
Simon Meier Skills
Angel Investing
Biopharmaceuticals
Biotechnology
Business Development
Business Strategy
Clinical Development
Corporate Development
Corporate Finance
Corporate Venture Capital
Diabetes Care
Drug Development
Drug Discovery
Due Diligence
Entrepreneurship
Finance
Financial Modeling
Funding
Growth Capital
In Vitro Diagnostics (IVD)
Innovation Management
Investments
Leadership
Life Sciences
Lifesciences
Management
Mergers & Acquisitions
Mobile Devices
Molecular Diagnostics
Mutual Funds
Negotiation
Oncology
Partnering
Pharmaceutical Industry
Private Equity
Sequencing
Start-ups
Strategic Leadership
Strategic Planning
Strategy
Team Leadership
Technology Transfer
Valuation
Venture Capital
Simon Meier Summary
Simon Meier, based in Basel, BS, CH, is currently a Chief Executive Officer at Oxford Cancer Analytics. Simon Meier brings experience from previous roles at IDUN Technologies, Corporate Venture Fund for non-disclosed Corporate Parent, several Healthtech and Life sciences companies and Komed Health AG. Simon Meier holds a 1994 - 1999 University of St.Gallen. With a robust skill set that includes Angel Investing, Biopharmaceuticals, Biotechnology, Business Development, Business Strategy and more. Simon Meier has 4 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Simon Meier?
Find contact details for 700 million professionals.